Pantoprazole in Cisplatin Nephrotoxicity
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Oncology
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Pantoprazole in Cisplatin NephrotoxicityPantoprazole in Cisplatin Nephrotoxicity. Is it protective?
Pantoprazole in Cisplatin NephrotoxicityPantoprazole in Cisplatin Nephrotoxicity. Is it protective?
Tracking Information
- NCT #
- NCT04217512
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Eman M Ghonaim, Msc Demonstrator of Clinical Pharmacy Principal Investigator: Sahar El-Haggar, Prof faculty of pharmacy- Tanta University Principal Investigator: Suzy Goher, Lecturer faculty of pharmacy- Tanta University
Get Well Soon